Stem Cells 
CAR-T 
AAV Delivery 
LVV Delivery 
Other Viral Vectors 
Extracellular Vesicles 
Nanoparticles 
Advanced Therapy Modalities
Artis supports a broad range of advanced therapy modalities through an integrated platform spanning synthetic DNA manufacturing, development, analytics, and GMP manufacturing. Our US and EU operations help streamline execution from starting material through clinical manufacturing.
Modalities Supported by the Artis Platform
Synthetic DNA Manufacturing
GMP-ready and RUO cell-free synthetic DNA produced enzymatically without plasmid dependency
CAR-T
Autologous and allogeneic CAR-T manufacturing support
Stem Cells
Development and manufacturing support for iPSC, MSC, and organoid-based programs
AAV Delivery
Scalable AAV development and GMP manufacturing
LVV Delivery
Integrated lentiviral vector development and manufacturing
Extracellular Vesicles
Process development, analytics, and manufacturing support for EV programs
Nanoparticles
Expanding mRNA and LNP capabilities spanning RNA production, formulation development, and scalable processing to support clinical translation
Designed to De-Risk, Accelerate, and Scale, All in House
Reduce technical & regulatory risk
Minimize external handoffs
Maintain process & data continuity
Accelerate transfer into GMP manufacturing
Scale efficiently while preserving product quality
Flexible Engagement Models
Artis offers flexible partnership models, from co-development and platform-based execution to full process transfer and GMP manufacturing, allowing clients to engage in the way that best fits their program needs.